Crossmark

Review: An Update on CGRP Monoclonal Antibodies for the Preventive Treatment of Episodic Migraine

Published Online: 2025-02-25

Published Print: 2025-12

Authors

Nicol, Kelly S

Burkett, John G
License Information

Text and Data Mining valid from 2025-02-25

Version of Record valid from 2025-02-25
More Information

Article History

Accepted: 30 January 2025

First Online: 25 February 2025

Declarations

:

: Competing Interests and Funding - received speaking fees from AbbVie Pharmaceuticals.

Document is current